Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  The Lancet

• Publication date

  1989-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(89)90430-3PMID 2569055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokines and other mediators in rheumatoid arthritis

  2004cited by this paper
• Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis

  2004cited by this paper
• Mechanism of immune complex‐mediated damage: induction of interleukin 1 by immune complexes and synergy with interferon‐γ and tumor necrosis factor‐α

  1989cited by this paper
• Effect of cytokines on HLA-DR and IL-1 production by a monocytic tumour, THP-1.

  1989cited by this paper
• A human inhibitor of tumor necrosis factor alpha

  1988cited by this paper
• IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma.

  1988cited by this paper
• The 1987 revised American Rheumatism Association criteria for rheumatoid arthritis.

  1988cited by this paper
• Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

  1988cited by this paper
• Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

  1988cited by this paper
• Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma.

  1988cited by this paper
• Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.

  1988cited by this paper
• Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.

  1987cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.

  1987cited by this paper
• ELISA for quantitation of tumor necrosis factor-alpha in serum.

  1987cited by this paper
• Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

  1986cited by this paper
• Evidence for existence of two distinct TNP-Ficoll-responsive B cell subpopulations preferentially reactive either to a T cell-replacing factor (B151-TRF) or to a signal from accessory cells.

  1986cited by this paper
• Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage

  1986cited by this paper
• Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

  1986cited by this paper
• Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

  1986cited by this paper
• Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.

  1985cited by this paper
• Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever

  1985cited by this paper
• Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

  1985cited by this paper
• An interleukin 1 like factor stimulates bone resorption in vitro

  1983cited by this paper
• The immunopathology of joint inflammation in rheumatoid arthritis.

  1973cited by this paper

• Role of macrophages and dendritic cells in autoimmune diseases: a specific focus on tumor necrosis factor targeting therapies against rheumatoid arthritis

  2026cites this paper
• Dioscorea nipponica Makino: Unraveling Multi-Target Mechanisms and Clinical Potential in Autoimmune Disease Therapy.

  2025cites this paper
• The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients

  2025cites this paper
• Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease

  2025cites this paper
• The potency of cell-based assays to predict response to TNF inhibitor therapy

  2025cites this paper
• microRNAs as Biomarkers and Therapeutic Targets in Rheumatoid Arthritis

  2025cites this paper
• A Brief Chronicle of Antibody Research and Technological Advances

  2024cites this paper
• A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease

  2024cites this paper
• Mir221/222 drive synovial hyperplasia and arthritis by targeting cell cycle inhibitors and chromatin remodeling components

  2024cites this paper
• Study on the Mechanism of the Combination of Methotrexate and Leflunomide in the Treatment of Rheumatoid Arthritis Based on Network Pharmacology, Molecular Docking, and in vitro Experimental Verification.

  2024cites this paper
• Treatments for early-stage Dupuytren’s disease: an evidence-based approach

  2023cites this paper
• Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach

  2023cites this paper
• Design and Evaluation of Polyherbal Nanogel for The Treatment of Rheumatoid Arthritis

  2023cites this paper
• Poor Translatability of Biomedical Research Using Animals — A Narrative Review

  2023cites this paper
• TNFα counteracts interleukin-10 anti-inflammatory pathway through the NOX2-Lyn-SHP-1 axis in human monocytes

  2023cites this paper
• Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications

  2023cites this paper
• Biogenetic Markers for Predicting Response to Immunotherapy in Rheumatoid Arthritis

  2023cites this paper
• Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts

  2023cites this paper
• 25 years of biologic DMARDs in rheumatology

  2023cites this paper
• Inhibitory Effect of Jinwujiangu Prescription on Peripheral Blood Osteoclasts in Patients with Rheumatoid Arthritis and the Relevant Molecular Mechanism

  2023cites this paper
• Calcium-sensing receptor-mediated NLRP3 inflammasome activation in rheumatoid arthritis and autoinflammation

  2023cites this paper
• A longitudinal single-cell therapeutic atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease

  2023cites this paper
• Health functions and related molecular mechanisms of Miconia genus: A systematic review

  2023cites this paper
• AB0072 BIOMARKER CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB WITH METHOTREXATE OR GLUCOCORTICOIDS VS TOFACITINIB MONOTHERAPY

  2023cites this paper
• Matrix metalloproteinases in arthritis: towards precision medicine

  2023cites this paper
• AB0072 BIOMARKER CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB WITH METHOTREXATE OR GLUCOCORTICOIDS VS TOFACITINIB MONOTHERAPY

  2023cites this paper
• The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases.

  2023cites this paper
• Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis

  2022cites this paper
• The Evolution of TNF-α Blockade for the Treatment of Rheumatoid Arthritis

  2022cites this paper
• Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-α inhibitors: a case series study

  2022cites this paper
• Death by TNF: a road to inflammation

  2022cites this paper
• Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs

  2022cites this paper
• Effect and Mechanism of siRNAs Targeting IL-1β/TNF-α Combined with BMSCs Transplantation in Ameliorating Rheumatoid Arthritis in Rats

  2022cites this paper
• miR-221/222 drive synovial fibroblast expansion and pathogenesis of TNF-mediated arthritis

  2022cites this paper
• Polystyrene Nanoplastics Toxicity to Zebrafish: Dysregulation of the Brain-Intestine-Microbiota Axis.

  2022cites this paper
• Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients

  2022cites this paper
• Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs

  2022cites this paper
• Causal Biological Network Model for Inflammasome Signaling Applied for Interpreting Transcriptomic Changes in Various Inflammatory States

  2022cites this paper
• Chronic cerebral aspects of long COVID, post‐stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic

  2022cites this paper
• Gene-selective transcription promotes the inhibition of tissue reparative macrophages by TNF

  2022cites this paper
• Inside the Joint of Inflammatory Arthritis Patients: Handling and Processing of Synovial Tissue Biopsies for High Throughput Analysis

  2022cites this paper
• How diseases caused by parasites allowed a wider understanding of disease in general: my encounters with parasitology in Australia and elsewhere over the last 50 years.

  2021cites this paper
• TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?

  2021cites this paper
• A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation

  2021cites this paper
• Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice

  2021cites this paper
• 80 Meilensteine der Rheumatologie aus 80 Jahren – III: 1980–2000

  2021cites this paper
• THE RELATIONSHIP BETWEEN THE LEVEL OF NESFATIN-1 AND THE CLINICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS

  2021cites this paper
• Quantity or quality? Exploring the association between public open space and mental health in urban China

  2021cites this paper
• Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor

  2021cites this paper
• Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19

  2021influential citation
• Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases

  2021cites this paper
• Interplay of Inflammatory, Antigen and Tissue-Derived Signals in the Development of Resident CD8 Memory T Cells

  2021cites this paper
• ENA-78/CXCL5 as a Predictive Factor for Baricitinib Effectiveness in Rheumatoid Arthritis

  2021cites this paper
• Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma

  2021cites this paper
• Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution

  2021cites this paper
• TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis.

  2021cites this paper
• Ulcerative colitis: shedding light on emerging agents and strategies in preclinical and early clinical development

  2021cites this paper
• Meilensteine der Rheumatologie aus 80 Jahren – III : 1980 – 2000 Vorbemerkung : Viele der in diesem

  2021cites this paper
• Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19

  2021cites this paper
• Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients

  2021cites this paper
• Bromelain Extract Exerts Antiarthritic Effects via Chondroprotection and the Suppression of TNF-α–Induced NF-κB and MAPK Signaling

  2021cites this paper
• Roles of IL‐1 and IL‐10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes?

  2021cites this paper
• Expression of sterile-α and armadillo motif containing protein (SARM) in rheumatoid arthritis monocytes correlates with TLR2-induced IL-1β and disease activity

  2021cites this paper
• The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes

  2021cites this paper
• Psoriasis Associated With Tumor Necrosis Factor Inhibitors in Children With Inflammatory Diseases

  2021cites this paper
• Common Tests for the Pelvic Floor

  2021cites this paper
• Expression of sterile-α and armadillo motif in rheumatoid arthritis monocytes correlates with TLR2 induced IL-1β and disease activity

  2021cites this paper
• TNF in the era of immune checkpoint inhibitors: friend or foe?

  2021cites this paper
• The Role of TNF-α in the Pathogenesis of Temporomandibular Disorders.

  2021cites this paper
• Appraisal of the Antiarthritic Potential of Prazosin via Inhibition of Proinflammatory Cytokine TNF-α: A Key Player in Rheumatoid Arthritis

  2021cites this paper
• Immunogenicity of TNF-Inhibitors

  2020cites this paper
• Death Receptors and Their Ligands in Inflammatory Disease and Cancer.

  2020cites this paper
• The science and medicine of human immunology

  2020cites this paper
• Screening and Quantification of TNF-α Ligand from Angelicae Pubescentis Radix by Biosensor and UPLC-MS/MS.

  2020cites this paper
• Insights into the treatment of rheumatoid arthritis: A paradigm in medicine.

  2020cites this paper
• University of Birmingham Responses to cytokine inhibitors associate with cellular composition in models of immune-mediated inflammatory arthritis

  2020cites this paper
• Network Pharmacology to Identify the Pharmacological Mechanisms of a Traditional Chinese Medicine Derived from Trachelospermum jasminoides in Patients with Rheumatoid Arthritis

  2020cites this paper
• Translational drug discovery and development with the use of tissue‐relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy

  2020cites this paper
• Viral arthritis and COVID-19

  2020cites this paper
• Surgical Treatment of Fecal Incontinence

  2020cites this paper
• Background to new treatments for COVID‐19, including its chronicity, through altering elements of the cytokine storm

  2020cites this paper
• Tackling the cytokine storm in COVID-19, challenges and hopes

  2020cites this paper
• Alternative splicing controls cell lineage-specific responses to endogenous innate immune triggers within the extracellular matrix.

  2020cites this paper
• Biologic agents and small-molecule inhibitors in systemic autoimmune conditions: an update.

  2020cites this paper
• CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile.

  2020cites this paper
• The trimer to monomer transition of Tumor Necrosis Factor-Alpha is a dynamic process that is significantly altered by therapeutic antibodies

  2020cites this paper
• Therapeutic targeting of JAKs: from hematology to rheumatology and from the first to the second generation of JAK inhibitors

  2020cites this paper
• Other Surgical Options for Anal Incontinence: From End Stoma to Stem Cell

  2020cites this paper
• Pharmacotherapy in pregnancy

  2020cites this paper
• The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens

  2020cites this paper
• Glaucoma after ocular surgery or trauma: the role of infiltrating monocytes and their response to cytokine inhibitors.

  2020cites this paper
• Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases.

  2020cites this paper
• Emerging Biological and Molecular Therapies in Autoimmune Disease

  2020cites this paper
• Infectious Complications of Biological Agents

  2020cites this paper
• Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer

  2020cites this paper
• Complex Procedures for Fecal Incontinence

  2020cites this paper
• Egg-derived Tripeptide IRW Attenuates LPS-induced Osteoclastogenesis in RAW 264.7 Macrophages via Inhibition of Inflammatory Responses and NF-κB/MAPK Activation.

  2020cites this paper
• Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

  2020cites this paper
• Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis

  2020cites this paper
• Inhibitors of tumor necrosis factor-a and mechanisms of their action

  2020cites this paper